EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹394 Cr | ₹286 Cr | ₹97 Cr | ₹12 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of EMCURE PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹394 Cr |
Mar2024 | ₹286 Cr |
Mar2023 | ₹97 Cr |
Mar2022 | ₹12 Cr |
Mar2021 | ₹13 Cr |
How is Contingent Liabilities of EMCURE PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹394 Cr | 37.98 | |
Mar2024 | ₹286 Cr | 194.49 | |
Mar2023 | ₹97 Cr | 703.28 | |
Mar2022 | ₹12 Cr | -5.66 | |
Mar2021 | ₹13 Cr | - |
Compare Contingent Liabilities of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹26,729.9 Cr | -0.1% | 12.5% | 3.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | -0.1% |
12.5% |
3.4% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses